利多卡因输液与氨酸输液对于儿科状态偏头痛的有效性
Marco Antonio Ayulo1, Sharaya Jenkins2, Thanh Le3
1Divisions of Pediatric Critical Care Medicine.
与酸相比,静脉注射利多卡因输液可以更快地缓解疼痛,并为儿科状态偏头痛提供更好的安全性. 这项研究强调了利多卡因作为患有严重偏头痛发作的儿童潜在的优越治疗选择.
科学领域:
- 神经学 神经学
- 儿科神经学 儿科神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 偏头痛状态是儿童和青少年的衰弱状况.
- 对于儿科状态偏头痛的当前治疗选择具有不同的疗效和安全性.
研究的目的:
- 为了比较静脉注射利多卡因输注与酸输注的疗效和安全性,用于治疗儿科状态偏头痛.
主要方法:
- 一项回顾性队列研究分析了94名患有偏头痛的儿科患者,他们接受了利多卡因或甲输液治疗.
- 收集的数据包括疼痛缓解的时间,出院时的无疼痛状态,输液中断和不良反应.
主要成果:
- 与氨酸相比,利多卡因输注导致明显更快的疼痛控制 (中位数为11.7小时而不是43.4小时) 和更高的无疼痛率 (67.7%而不是44.1%).
- 与利多卡因相比,氨酸输注的中断次数更多 (25.4%与3.2%) 和不良反应的发生率更高 (67%与3.2%).
结论:
- 静脉注射利多卡因输液在疼痛控制方面表现出更高的疗效,并且与酸输液相比,在儿童偏头痛状态下具有更好的安全性.
- 利多卡因应被认为是治疗儿科患者严重偏头痛发作的首选治疗方案.
更多相关视频
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
相关概念视频
Parenteral Anesthetics: Overview
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Depolarizing Blockers: Pharmocokinetics
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
